Family Medicine Doctors in Sun City, CA Accepting Medicare

3 Family Medicine doctors found. Showing 1 - 3

Mary Chau, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 28125 Bradley Rd, Suite 240b, Sun City, CA 92586 Phone: 951-301-6366    Fax: 951-301-6366

Dr. Susan Mary Danek, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 29798 Haun Rd, Suite 302, Sun City, CA 92586 Phone: 951-301-7191    Fax: 951-301-4160

John Overman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 26960 Cherry Hills Blvd Ste 203, Sun City, CA 92586 Phone: 951-301-1100    Fax: 951-679-5851

News Archive

Mindfit brain fitness program helps frail seniors walk faster

Computerized brain fitness programs are known to help seniors improve their memory and focus. Now, a study led by researchers at Albert Einstein College of Medicine of Yeshiva University has found preliminary evidence that such programs may help frail seniors walk faster, potentially preventing disability and improving quality of life. Results appear in the July 19 online edition of the Journal of Gerontology.

Kids with autism show the biggest drop in physical activity between ages 9 to 13

A recent study from Oregon State University has found that to best help kids with autism maintain healthy rates of physical activity, interventions should be targeted during the ages of 9 to 13, as that's when kids show the biggest drop in active time.

FDA approves NAMENDA XR for treatment of Alzheimer's type dementia

Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.

Scientists look for new antibiotic drugs in unexpected places

Many of the drugs we use in hospitals – antibiotics, antifungals and anti-cancer drugs, to name but a few – are produced by bacteria that live in the soil beneath our feet.

EC approves CTI's Pixuvri to treat multiply relapsed or refractory aggressive NHL

Cell Therapeutics, Inc. today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.

Read more Medical News

› Verified 6 days ago